Home Weight loss (GLP-1) By insurer Losing coverage
Losing GLP-1 coverage in 2027? Your options
Fewer employers cover GLP-1s to treat obesity: 60% in 2026, down from 72% in 2025, in Business Group on Health's 2027 survey of 127 employers. If your plan drops Wegovy or Zepbound for 2027, check what exactly ends, ask about the preferred form or a coverage review, or switch to a self-pay program from $59 a month (a sale price, read Nov 12, 2026).
Coverage ending? Self-pay GLP-1 programs
No prior authorization or plan year: a licensed clinician online and a price you see before you pay. Price tables are sorted cheapest first.
How we picked
Every program here is prescribed online by a US-licensed clinician, fills prescriptions through a licensed US pharmacy and lets you start without an office visit. Each card shows the price we read on the program's own site (or says when a program prices only after its intake) and what that price covers, and we keep the date of every read; some programs bill a membership and the medication separately, and the card says so. The label on each card says what that program stands out for. How we check prices and programs.
Compounded semaglutide: lowest monthly price
| # | Program | Lowest price | Month to month | Notes | Link |
|---|---|---|---|---|---|
| 1 | SnagRxCheapest | $59/mo | $59/mo | pre-Black Friday sale price (was $299), locked in; the page counts down to a price increase | VisitSnagRx |
| 2 | Lttl | $89/mo 12-month plan | $99 / 4 wks | 4-week supply | VisitLttl |
| 3 | yourEra | $96/mo 12-month plan | $186/mo | $1,152 billed upfront; same price at every dose; Black Friday: 25% off every plan at checkout | VisityourEra |
| 4 | HealthRX | $97/mo 12-month plan | Not offered | charged every month; $39 first month on every plan | VisitHealthRX |
| 5 | BetterMe Rx | $99/mo 12-month plan | $199/mo | VisitBetterMe Rx |
Compounded tirzepatide: lowest monthly price
| # | Program | Lowest price | Month to month | Notes | Link |
|---|---|---|---|---|---|
| 1 | yourEraCheapest | $96/mo 12-month plan | $186/mo | $1,152 billed upfront; same price at every dose; Black Friday: 25% off every plan at checkout | VisityourEra |
| 2 | Maximus | $99.99/mo 12-month plan | Not offered | paid up front; $199.99 on 2 months | VisitMaximus |
| 3 | SnagRx | $109/mo | $109/mo | pre-Black Friday sale price (was $349), locked in; the page counts down to a price increase | VisitSnagRx |
| 4 | Lttl | $139/mo 12-month plan | $149 / 4 wks | 4-week supply | VisitLttl |
| 5 | BetterMe Rx | $159/mo 12-month plan | $249/mo | VisitBetterMe Rx |
- 120-day weight-loss guarantee#1
Black Friday price locked inCompounded semaglutide from $159 a month, with a health coach included
- Black Friday: semaglutide $175/mo, tirzepatide $225/mo, billed every 2 months and locked in
- First-time GLP-1 users: lose 5% in 120 days or your money back, if you keep the coaching and check-in commitments
- Same price at every dose; under-the-tongue drops and lozenges too; HSA/FSA eligible
Comes asInjection or drops or troche
Semaglutide from$159/moon the 12-month plan ($1,908 up front); $179 on 6 months; $199 month to month (28-day billing); Black Friday $175/mo billed $350 every 2 months4.6 on Trustpilot1,084 reviews ·Visit SHED Read our SHED review - Low-cost tirzepatide#2
Same price at every doseCompounded tirzepatide from $99.99 a month
- One flat rate covers every dose, with no membership fee
- Online evaluation in about 5 minutes, no appointment needed
- Free shipping in discreet packaging, HSA/FSA accepted
Comes asVial
Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months4.4 on Trustpilot1,106 reviews ·Visit Maximus Read our Maximus review - Sale price locked in#3
Pre-Black Friday sale: was $299Compounded semaglutide for $59 a month during its sale
- Tirzepatide $109/mo; same price at every dose, every month
- No membership, no hidden fees, cancel anytime
- Rx written in about a day, delivered in 1-2 days
Comes asInjection
Semaglutide$59/moduring the pre-Black Friday sale (was $299); the page counts down to a price increase and says the sale price is locked in for lifeVisit SnagRx Read our SnagRx review - Brand-name only#4
Labs every 90 days includedBrand-name GLP-1 care with quarterly labs, one flat fee
- Wegovy, Zepbound, Mounjaro or Ozempic; never compounded
- Lab panel every 90 days, monthly clinician check-ins and unlimited chat
- Medication billed by your pharmacy at its own price, no markup
Membership$299/moplus medication at pharmacy cost; 2-month start ($598 held at checkout)Visit GoodLife Read our GoodLife review - Low month-to-month#5
Up to $140 off your first monthCompounded semaglutide for $99, month to month
- Same price at every dose, no long contract needed
- $89/mo semaglutide or $139/mo tirzepatide on a 12-month plan
- Available in all 50 states
Comes asVial or under the tongue
Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month planVisit Lttl Read our Lttl review - Overnight shipping#6
$39 first monthCompounded semaglutide from $97 a month
- $39 first month on every plan, then from $97/mo on the 12-month plan; tirzepatide $39, then from $177
- Provider review in about 24 hours; free overnight shipping
- Full refund if a provider does not approve you; LegitScript certified
Comes asVial
Semaglutide from$97/moon the 12-month plan, billed monthly after a $39 first monthVisit HealthRX Read our HealthRX review - Low yearly price#7
Black Friday: 25% off at checkoutCompounded semaglutide or tirzepatide from $96 a month on a yearly plan
- $186/mo month to month, cancel anytime; tirzepatide is the same price
- Same plan price at every dose
- A licensed provider reviews every visit; unlimited care-team messaging
Comes asVial
Semaglutide$96/moon the 12-month plan ($1,152 billed upfront); $186 month to monthVisit yourEra Read our yourEra review
What to do when your plan drops GLP-1 coverage
Read your 2027 benefits summary and drug list
Open enrollment documents name the drugs your plan covers next year. Look for the weight-loss drug line, the formulary your pharmacy benefit uses, and whether prior authorization rules changed.
Ask exactly what is ending
Ask your plan or HR whether the change ends coverage for weight-loss use only or also for other uses, whether it applies to one form (for example a pen type) or the whole drug, and the date it starts.
If one form is dropped, ask about the preferred one
A formulary can keep one form of a drug and drop another. Express Scripts' 2027 National Preferred Formulary, for example, excludes Zepbound KwikPens and vials but lists Zepbound single-dose pens and Wegovy pens and tablets as preferred alternatives. Your prescriber can switch the prescription.
Ask for a coverage review if there is a clinical reason
Express Scripts' exclusion list says that if your physician identifies a clinical reason you need to stay on an excluded drug, they can request a coverage review. Other plans have their own exception and appeal process; your plan documents name it.
Use pre-tax money
If you have an HSA or FSA, several programs we compare say those cards can pay. See which ones, in their own words, on our HSA and FSA page.
Switch to a self-pay program
Self-pay programs don't depend on your plan year: an online clinician decides, and the program shows its price before you pay. In the programs we compare, compounded semaglutide starts at $59 a month (SnagRx's pre-Black Friday sale price, locked in; the page counts down to a price increase; read Nov 12, 2026) and compounded tirzepatide at $96 a month on a 12-month plan billed upfront (read Nov 12, 2026). Compounded medicines are not FDA-approved; a compounding pharmacy makes them.
More: programs that say HSA or FSA can pay, coverage rules by insurer, GLP-1 without insurance, every 2027 price and coverage change.
The dated facts behind this page
In Business Group on Health's 2027 Employer Healthcare Strategy Survey (127 employers), coverage of GLP-1s to treat obesity dropped from 72% of employers in 2025 to 60% in 2026.
Source: Business Group on Health, 2027 Employer Healthcare Strategy Survey. Read Nov 8, 2026.
In an earlier Business Group on Health GLP-1 survey (105 employers, completed February to March 2026), of the employers covering GLP-1s for weight management, 72% said they were likely to continue that coverage in 2027 and 10% said they likely would not.
Source: Business Group on Health GLP-1 survey (completed Feb-Mar 2026). Read Nov 8, 2026.
The Express Scripts 2027 National Preferred Formulary excludes Zepbound KwikPens and Zepbound vials. The preferred alternatives it lists are liraglutide, Foundayo, Wegovy HD, Wegovy pens, Wegovy tablets and Zepbound (single-dose) pens.
Source: Express Scripts: 2027 National Preferred Formulary Exclusions. Read Nov 8, 2026.
Novo Nordisk lowers the list price of Wegovy injection 2.4 mg and tablets 25 mg, Ozempic 0.5, 1 and 2 mg, and Rybelsus 7 and 14 mg to $675 a month from January 1, 2027. Novo Nordisk says the decision applies to all doses of these medicines, and that the list-price change does not affect its direct-to-patient self-pay prices.
Source: Novo Nordisk press release, Feb 24, 2026. Read Nov 8, 2026.
The Medicare GLP-1 Bridge, with a $50 copay for eligible Part D members, runs from July 1, 2026 and is extended through December 31, 2027.
Source: CMS: Medicare GLP-1 Bridge (page updated Jul 13, 2026). Read Nov 8, 2026.
Questions about losing GLP-1 coverage
Are employers dropping GLP-1 coverage in 2027?
Some are. In Business Group on Health's 2027 survey of 127 employers, coverage of GLP-1s to treat obesity dropped from 72% of employers in 2025 to 60% in 2026. In its earlier GLP-1 survey (105 employers, completed February to March 2026), of the employers covering GLP-1s for weight management, 72% said they were likely to continue that coverage in 2027 and 10% said they likely would not.
Does Express Scripts cover Zepbound in 2027?
On its 2027 National Preferred Formulary, Zepbound single-dose pens are a preferred alternative, and Zepbound KwikPens and vials are excluded. Your plan may use a different Express Scripts formulary, so check your own drug list.
Can I appeal if my plan stops covering Wegovy?
If the plan excludes weight-loss drugs as a benefit, an appeal works within that exclusion; your plan documents say whether any exception exists. If one form or drug is excluded and you have a clinical reason to stay on it, your prescriber can ask for a coverage review or exception.
What if I am on Medicare?
If you are on Medicare, weight-loss coverage comes through the $50 Medicare GLP-1 Bridge (through December 31, 2027, for Part D members who meet its rules), not your plan's drug list. See Medicare and GLP-1s.
Will the 2027 list-price cut help if I keep coverage?
It can, if you pay coinsurance or are in your deductible: Novo Nordisk lowers the list price of Wegovy, Ozempic and Rybelsus to $675 a month from January 1, 2027.
Is self-pay cheaper than my insurance?
Not always. If your plan covers your drug with a low copay, using the plan can cost less. If coverage ends, a self-pay program shows its own price, without prior authorization.